| abstract |
Disclosed herein are β-tubulin inhibitors of formula (I), prodrugs thereof and therapeutically acceptable salts thereof, wherein R is selected from the group consisting of: t-butyl, l-propyl and sec-butyl and their use as anti-cancer cell proliferation agents. |